Department of Surgery, Division of Urology, McMaster University, Hamilton, ON.
Central to the malignant behaviour that endows cancer cells with growth advantage is their unique metabolism. Cancer cells can process nutrient molecules differently from normal cells and use it to overcome stress imposed on them by various therapies. This metabolic conversion is controlled by specific genetic mutations that are associated with activation of oncogenes and loss of tumour suppressor proteins. Understanding these processes is important as it can lead to the discovery of biomarkers that can predict the aggressiveness of the disease and its response to therapy, and even more importantly, to the development of novel therapeutics. A classic tumour in this respect is clear-cell renal cell carcinoma (RCC). In this review, we will begin with a brief summary of normal cellular bioenergetic pathways, which will be followed by a description of the characteristic metabolism of glucose and lipids in clear-cell RCC cells and its clinical implications. Data relating to the potential effect of dietary nutrients on RCC will also be reviewed along with potential therapies targeted at interrupting specific metabolic pathways in clear-cell RCC.
Written by:
Pinthus JH, Whelan KF, Gallino D, Lu JP, Rothschild N. Are you the author?
Reference: Can Urol Assoc J. 2011 Aug;5(4):274-82.
doi: 10.5489/cuaj.10196
PubMed Abstract
PMID: 21801687
UroToday.com Renal Cancer Section
